tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MBRX Stock Latest News

Moleculin Biotech Appoints Adriano Treve as Strategic Advisor
Company AnnouncementsMoleculin Biotech Appoints Adriano Treve as Strategic Advisor
9d ago
8K
MBRX
Moleculin Biotech appoints Adriano Treve as strategic advisor
PremiumThe Fly
Moleculin Biotech appoints Adriano Treve as strategic advisor
9d ago
MBRX
Moleculin Biotech Enters New Stock Offering Agreement
PremiumCompany Announcements
Moleculin Biotech Enters New Stock Offering Agreement
15d ago
8K
MBRX
Moleculin Biotech’s Clinical and Regulatory Advances Drive Buy Rating Amid Promising Phase 3 MIRACLE Study and FDA Feedback
PremiumRatings
Moleculin Biotech’s Clinical and Regulatory Advances Drive Buy Rating Amid Promising Phase 3 MIRACLE Study and FDA Feedback
17d ago
MBRX
Moleculin Biotech Gains Approval for Phase 2B/3 AML Study
PremiumCompany Announcements
Moleculin Biotech Gains Approval for Phase 2B/3 AML Study
17d ago
8K
MBRX
Moleculin Biotech receives approval for pivotal Phase 2B/3 study of Annamycin
PremiumThe FlyMoleculin Biotech receives approval for pivotal Phase 2B/3 study of Annamycin
17d ago
MBRX
Moleculin Biotech Faces Nasdaq Delisting Warning
Premium
Company Announcements
Moleculin Biotech Faces Nasdaq Delisting Warning
29d ago
8K
MBRX
Moleculin Biotech price target lowered to $13 from $20 at Roth Capital
Premium
The Fly
Moleculin Biotech price target lowered to $13 from $20 at Roth Capital
29d ago
MBRX
Moleculin Biotech Raises $5.9M in Public Offering
PremiumCompany Announcements
Moleculin Biotech Raises $5.9M in Public Offering
1M ago
8K
MBRX
Moleculin Biotech prices 16.08M shares at 37c in public offering
PremiumThe Fly
Moleculin Biotech prices 16.08M shares at 37c in public offering
1M ago
MBRX
Promising Developments and Regulatory Progress Drive Buy Rating for Moleculin Biotech’s Annamycin
PremiumRatings
Promising Developments and Regulatory Progress Drive Buy Rating for Moleculin Biotech’s Annamycin
1M ago
MBRX
Moleculin Biotech’s Annamycin Pediatric Study Approved by FDA
PremiumCompany Announcements
Moleculin Biotech’s Annamycin Pediatric Study Approved by FDA
1M ago
8K
MBRX
Moleculin Biotech receives FDA feedback on pediatric study plan for Annamycin
PremiumThe FlyMoleculin Biotech receives FDA feedback on pediatric study plan for Annamycin
1M ago
MBRX
Moleculin Biotech announces ‘What This Means’ virtual investor segment
Premium
The Fly
Moleculin Biotech announces ‘What This Means’ virtual investor segment
2M ago
MBRX
Moleculin Biotech assumed with a Buy at H.C. Wainwright
Premium
The Fly
Moleculin Biotech assumed with a Buy at H.C. Wainwright
2M ago
MBRX
Moleculin Biotech: Positive Clinical Trial Results and Strategic Developments Support Buy Rating
PremiumRatings
Moleculin Biotech: Positive Clinical Trial Results and Strategic Developments Support Buy Rating
2M ago
MBRX
Moleculin Biotech Hosts Key Opinion Leaders Event
PremiumCompany Announcements
Moleculin Biotech Hosts Key Opinion Leaders Event
2M ago
8K
MBRX
Moleculin Biotech releases KOL webcast to discuss Phase 1B/2 annamycin data
PremiumThe Fly
Moleculin Biotech releases KOL webcast to discuss Phase 1B/2 annamycin data
2M ago
MBRX
Moleculin Biotech Stock (MBRX) Dives 10% on Clinical Trial Results
PremiumMarket News
Moleculin Biotech Stock (MBRX) Dives 10% on Clinical Trial Results
2M ago
MBRX
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
PremiumMarket NewsMorning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
2M ago
KO
BTC
Moleculin Biotech Reports Positive Annamycin Trial Results
Premium
Company Announcements
Moleculin Biotech Reports Positive Annamycin Trial Results
2M ago
8K
MBRX
Moleculin Biotech reports efficacy results from Phase 1B/2 trial of annamycin
Premium
The Fly
Moleculin Biotech reports efficacy results from Phase 1B/2 trial of annamycin
2M ago
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >